Virax Biolabs is a biotechnology company focusing on the prevention, detection, and diagnosis of viral diseases.
Virax Biolabs has raised $3.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2026.
Virax Biolabs is headquartered in London, United Kingdom.
Virax Biolabs is a biotechnology company focusing on the prevention, detection, and diagnosis of viral diseases.
Virax Biolabs is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Virax Biolabs — Funding & Investors." VCBacked, July 9, 2026, https://www.vcbacked.co/company/virax-biolabs. Accessed August 13, 2026.
VCBacked. (2026). Virax Biolabs — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/virax-biolabs
{{cite web |title=Virax Biolabs — Funding & Investors |url=https://www.vcbacked.co/company/virax-biolabs |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated